Continuous subcutaneous infusion of opiates at end-of-life

Annals of Pharmacotherapy

Volumn 38, Issue 6, 2004, Pages 1015-1023

  Anderson, Stacey L ^a,c   Shreve, Scott T ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

Fentanyl; Hospices; Hydromorphone; Morphine; Narcotics; Palliative care; Subcutaneous

Indexed keywords

FENTANYL; HYDROMORPHONE; METHADONE; MORPHINE; OPIATE DERIVATIVE; OXYCODONE;

CLINICAL TRIAL; CONFUSION; CONSTIPATION; DRUG ABSORPTION; DRUG HALF LIFE; DRUG INFUSION; DRUG METABOLISM; DRUG SAFETY; ERYTHEMA; HUMAN; INFECTION; MYOCLONUS; NAUSEA; NECROSIS; PALLIATIVE THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATION DEPRESSION; RETROSPECTIVE STUDY; REVIEW; SEDATION; SIDE EFFECT; SKIN IRRITATION; SYSTEMATIC REVIEW; TERMINAL CARE; TERMINAL DISEASE;

ANALGESICS, OPIOID; CLINICAL TRIALS; DRUG ADMINISTRATION SCHEDULE; HUMANS; INFUSION PUMPS; INJECTIONS, SUBCUTANEOUS; PAIN; TERMINAL CARE;

EID: 2442669502     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1D395     Document Type: Review

References (34)

1. Day H. The treatment of infantile diarrhea by saline injections. Practitioner 1913;91:58-64.
2. Russell PS. Analgesia in terminal malignant disease (letter). Br Med J 1979;1:1561.
3. Storey P, Hill HH Jr, St. Louis RH, Tarver EE. Subcutaneous infusions for control of cancer symptoms. J Pain Symptom Manage 1990;5:33-41.
4. Herndon CM, Fike DS. Continuous subcutaneous infusion practices of United States hospices. J Pain Symptom Manage 2001;22:1027-34.
5. Moulin DE, Johnson NG, Murray-Parsons N, Geoghegan MF, Goodwin VA, Chester MA. Subcutaneous narcotic infusions for cancer pain: treatment outcome and guidelines for use. CMAJ 1992;146:891-7.
6. Coyle N, Cherny NI, Portenoy RK. Subcutaneous opioid infusions at home. Oncology (Huntingt) 1994;8:21-7, 31-2, 37.
7. Macmillan K, Bruera E, Kuehn N, Selmser P, Macmillan A. A prospective comparison study between a butterfly needle and a Teflon cannula for subcutaneous narcotic administration. J Pain Symptom Manage 1994;9:82-4.
8. Ross JR, Saunders Y, Cochrane M, Zeppetella G. A prospective, within-patient comparison between metal butterfly needles and Teflon cannulae in subcutaneous infusion of drugs to terminally ill hospice patients. Palliat Med 2002;16:13-6.
9. Torre MC. Subcutaneous infusion: non-metal cannulae vs metal butterfly needles. Br J Commun Nurs 2002;7:365-9.
10. Levy MH. Pharmacologic treatment of cancer pain. N Engl J Med 1996;335:1124-32.
11. Payne R. Opioid pharmacotherapy. In: Berger AM, Portenoy RK, Weissman DE, eds. Principles and practice of palliative care & supportive oncology. 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 2002:68-83.
12. Hutchison TA, Shahan DR, eds. DRUGDEX system. Greenwood Village, CO: Micromedex (expired 12/2002).
13. Challinger YC, Jarrett D, Hayward MJ, al-Jubouri MA, Julious SA. A comparison of intravenous and subcutaneous hydration in elderly acute stroke patients. Postgrad Med 1994;70:195-7.
14. Stuart-Harris R, Joel SP, McDonald P, Currow D, Slevin ML. The pharmacokinetics of morphine and morphine glucuronide metabolites after subcutaneous bolus injection and subcutaneous infusion of morphine. Br J Clin Pharmacol 2000;49:207-14.
15. Adams F, Cruz L, Deachman MJ, Zamora E. Plaques may complicate subcutaneous opioid infusions. Am J Nurs 1989;89:109-10.
16. Bruera E, MacEachern T, Ripamonti C, Hanson J. Subcutaneous morphine for dyspnea in cancer patients. Ann Intern Med 1993;119:906-7.
17. Bruera E, Neumann CM, Pituskin E, Calder K, Hanson J. A randomized controlled trial of local injections of hyaluronidase versus placebo in cancer patients receiving subcutaneous hydration. Ann Oncol 1999;10:1255-8.
18. Campbell CF, Mason JB, Weiler M. Continuous subcutaneous infusion of morphine for the pain of terminal malignancy. Ann Intern Med 1983;98:51-2.
19. Centeno C, Bruera E. Subcutaneous hydration with no hyaluronidase in patients with advanced cancer (letter). J Pain Symptom Manage 1999;17:305-6.
20. Reisine T, Pasternak G. Opioid analgesics and antagonists. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, eds. Goodman & Gilman's the pharmacological basis of therapeutics. 9th ed. New York: McGraw-Hill, 1996:521-56.
21. Wolff T, Samuelsson H, Hedner T. Concentrations of morphine and morphine metabolites in CSF and plasma during continuous subcutaneous morphine administration in cancer pain patients. Pain 1996;68:209-16.
22. Hunt R, Fazekas B, Thorne D, Brooksbank M. A comparison of subcutaneous morphine and fentanyl in hospice cancer patients. J Pain Symptom Manage 1999;18:111-9.
23. Miller MG, McCarthy N, O'Boyle CA, Kearney M. Continuous subcutaneous infusion of morphine vs. hydromorphone: a controlled trial. J Pain Symptom Manage 1999;18:9-16.
24. Nelson KA, Glare PA, Walsh D, Groh ES. A prospective, within-patient, crossover study of continuous intravenous and subcutaneous morphine for chronic cancer pain. J Pain Symptom Manage 1997;13:262-7.
25. Kalso E, Heiskanen T, Rantio M, Rosenberg PH, Vainio A. Epidural and subcutaneous morphine in the management of cancer pain: a double-blind cross-over study. Pain 1996;67:443-9.
26. Vanier M, Labrecque G, Lepage-Savary D, Poulin E, Provencher L, Lamontagne C. Comparison of hydromorphone continuous subcutaneous infusion and basal rate subcutaneous infusion plus PCA in cancer pain: a pilot study. Pain 1993;53:27-32.
27. Moulin DE, Kreeft JH, Murray-Parsons N, Bouquillon AI. Comparison of continuous subcutaneous and intravenous hydromorphone infusions for management of cancer pain. Lancet 1991;337:465-7.
28. Lang AH, Abbrederis K, Dzien A, Drexel H. Treatment of severe cancer pain by continuous infusion of subcutaneous opioids. Recent Results Cancer Res 1991;121:51-7.
29. Bruera E, Brenneis C, Michaud M, MacMillan K, Hanson J, MacDonald RN. Patient-controlled subcutaneous hydromorphone versus continuous subcutaneous infusion for the treatment of cancer pain. J Natl Cancer Inst 1988;80:1152-4.
30. Kerr IG, Sone M, Deangelis C, Iscoe N, MacKenzie R, Schueller T. Continuous narcotic infusion with patient-controlled analgesia for chronic cancer pain in outpatients. Ann Intern Med 1988;108:554-7.
31. Watanabe S, Pereira J, Hanson J, Bruera E. Fentanyl by continuous subcutaneous infusion for the management of cancer pain: a retrospective study. J Pain Symptom Manage 1998;16:323-6.
32. Enck RE. The role of continuous intravenous and subcutaneous narcotic infusions in pain management. Am J Hosp Care 1987;4(6):43-5.
33. Noda J, Umeda S, Arai T, Harima A, Mori K. Continuous subcutaneous infusion of buprenorphine for cancer pain control. Clin J Pain 1989;5:147-52.
34. Mystakidou K, Befon S, Hondros K, Kouskouni E, Vlahos L. Continuous subcutaneous administration of high-dose salmon calcitonin in bone metastasis: pain control and beta-endorphin plasma levels. J Pain Symptom Manage 1999;18:323-30.